Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Ovary Syndrome | 14 | 2009 | 207 | 0.960 |
Why?
|
| Ovary | 10 | 2005 | 262 | 0.730 |
Why?
|
| Embryo Transfer | 4 | 2014 | 30 | 0.640 |
Why?
|
| Androgens | 11 | 2002 | 175 | 0.550 |
Why?
|
| Infertility | 2 | 2014 | 35 | 0.540 |
Why?
|
| Hirsutism | 6 | 2003 | 61 | 0.500 |
Why?
|
| Medical Staff | 1 | 2014 | 10 | 0.470 |
Why?
|
| Live Birth | 1 | 2014 | 18 | 0.460 |
Why?
|
| Luteinizing Hormone | 13 | 2002 | 167 | 0.430 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 126 | 0.420 |
Why?
|
| Nafarelin | 10 | 1997 | 43 | 0.410 |
Why?
|
| Fertilization in Vitro | 6 | 2014 | 57 | 0.390 |
Why?
|
| Gonadotropin-Releasing Hormone | 7 | 2000 | 106 | 0.370 |
Why?
|
| Hyperandrogenism | 5 | 1997 | 43 | 0.350 |
Why?
|
| Follicle Stimulating Hormone | 8 | 2009 | 147 | 0.310 |
Why?
|
| Estrogens | 4 | 1998 | 200 | 0.310 |
Why?
|
| Testosterone | 11 | 2002 | 272 | 0.300 |
Why?
|
| Leuprolide | 2 | 1997 | 35 | 0.280 |
Why?
|
| Pregnancy Rate | 3 | 2014 | 21 | 0.270 |
Why?
|
| Ovarian Follicle | 4 | 2009 | 72 | 0.270 |
Why?
|
| Adrenal Gland Diseases | 2 | 1994 | 14 | 0.220 |
Why?
|
| Ovarian Diseases | 4 | 1995 | 32 | 0.210 |
Why?
|
| Ovarian Cysts | 1 | 2002 | 17 | 0.200 |
Why?
|
| Female | 42 | 2014 | 46587 | 0.190 |
Why?
|
| Hormone Replacement Therapy | 1 | 2001 | 86 | 0.170 |
Why?
|
| Hormones | 3 | 1997 | 139 | 0.170 |
Why?
|
| Estradiol | 6 | 2005 | 250 | 0.160 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 3 | 1993 | 22 | 0.150 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2000 | 131 | 0.150 |
Why?
|
| Obesity | 3 | 2013 | 972 | 0.150 |
Why?
|
| Dexamethasone | 8 | 2002 | 343 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 539 | 0.150 |
Why?
|
| Steroids | 3 | 2009 | 173 | 0.140 |
Why?
|
| Pregnancy | 9 | 2014 | 3046 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1997 | 145 | 0.130 |
Why?
|
| Oocytes | 3 | 2010 | 219 | 0.130 |
Why?
|
| Adult | 25 | 2014 | 26816 | 0.130 |
Why?
|
| Humans | 42 | 2014 | 89961 | 0.130 |
Why?
|
| Reproductive Health | 2 | 2013 | 34 | 0.130 |
Why?
|
| Virilism | 1 | 1994 | 6 | 0.120 |
Why?
|
| Neurosecretory Systems | 1 | 1994 | 36 | 0.120 |
Why?
|
| Reproductive Medicine | 1 | 2014 | 8 | 0.120 |
Why?
|
| Ovarian Neoplasms | 2 | 1997 | 772 | 0.110 |
Why?
|
| Menstruation Disturbances | 1 | 1993 | 24 | 0.110 |
Why?
|
| Menstruation | 1 | 1993 | 35 | 0.110 |
Why?
|
| Adrenal Glands | 1 | 1993 | 77 | 0.110 |
Why?
|
| Chorionic Gonadotropin | 3 | 2009 | 72 | 0.110 |
Why?
|
| HLA-DQ Antigens | 1 | 1992 | 51 | 0.100 |
Why?
|
| Infertility, Female | 2 | 2012 | 96 | 0.100 |
Why?
|
| Adolescent | 11 | 2013 | 9340 | 0.100 |
Why?
|
| Hyperinsulinism | 3 | 1998 | 47 | 0.100 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 5 | 2002 | 31 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2014 | 2886 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 225 | 0.100 |
Why?
|
| Bronchial Spasm | 1 | 1991 | 15 | 0.100 |
Why?
|
| Carboprost | 1 | 1991 | 3 | 0.100 |
Why?
|
| Ultrasonography | 4 | 2005 | 720 | 0.090 |
Why?
|
| Acupuncture Therapy | 1 | 2010 | 10 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1214 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 344 | 0.090 |
Why?
|
| Intubation, Intratracheal | 1 | 1991 | 147 | 0.090 |
Why?
|
| Hydroxyprogesterones | 4 | 1994 | 22 | 0.080 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1989 | 22 | 0.080 |
Why?
|
| Abortion, Habitual | 2 | 1999 | 33 | 0.080 |
Why?
|
| Glucocorticoids | 2 | 2002 | 357 | 0.080 |
Why?
|
| Puberty, Precocious | 2 | 2000 | 36 | 0.080 |
Why?
|
| Pregnancy Outcome | 4 | 2003 | 258 | 0.070 |
Why?
|
| Ovarian Function Tests | 3 | 2000 | 8 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 3022 | 0.070 |
Why?
|
| Inhibins | 2 | 2009 | 37 | 0.070 |
Why?
|
| Theca Cells | 3 | 2009 | 12 | 0.070 |
Why?
|
| Serum Amyloid P-Component | 1 | 2005 | 5 | 0.060 |
Why?
|
| Endometrium | 1 | 2005 | 50 | 0.060 |
Why?
|
| Granulosa Cells | 2 | 2009 | 32 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2014 | 9210 | 0.060 |
Why?
|
| Ovulation Induction | 3 | 2005 | 31 | 0.060 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 1997 | 17 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 192 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2014 | 8273 | 0.060 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2003 | 8 | 0.060 |
Why?
|
| Embryo Implantation | 1 | 2003 | 26 | 0.060 |
Why?
|
| Hair Follicle | 1 | 2003 | 29 | 0.050 |
Why?
|
| Hair | 1 | 2003 | 56 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 1996 | 328 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 693 | 0.050 |
Why?
|
| Alleles | 2 | 1998 | 1137 | 0.050 |
Why?
|
| Women's Health | 1 | 2001 | 103 | 0.040 |
Why?
|
| Oligospermia | 1 | 1999 | 4 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 1999 | 8 | 0.040 |
Why?
|
| Testicular Diseases | 1 | 1999 | 9 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1452 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1606 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 1998 | 141 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 148 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 1999 | 94 | 0.040 |
Why?
|
| Monocytes | 1 | 1999 | 221 | 0.040 |
Why?
|
| Androstenedione | 3 | 1997 | 29 | 0.040 |
Why?
|
| Calcinosis | 1 | 1999 | 230 | 0.040 |
Why?
|
| Models, Biological | 3 | 1997 | 1766 | 0.040 |
Why?
|
| Immunoconjugates | 1 | 1998 | 114 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1999 | 197 | 0.040 |
Why?
|
| Time Factors | 4 | 2003 | 5358 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 1997 | 110 | 0.040 |
Why?
|
| Ovulation | 1 | 1997 | 68 | 0.030 |
Why?
|
| Receptors, LH | 1 | 1996 | 7 | 0.030 |
Why?
|
| 17-alpha-Hydroxypregnenolone | 2 | 1994 | 12 | 0.030 |
Why?
|
| Feedback | 1 | 1997 | 134 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 1997 | 119 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 1997 | 138 | 0.030 |
Why?
|
| Child | 2 | 2000 | 7240 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 1134 | 0.030 |
Why?
|
| Genotype | 3 | 1998 | 1852 | 0.030 |
Why?
|
| Hydrolases | 1 | 1994 | 30 | 0.030 |
Why?
|
| Male | 10 | 2003 | 42674 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2655 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 208 | 0.030 |
Why?
|
| Kinetics | 2 | 1997 | 1534 | 0.030 |
Why?
|
| Clomiphene | 2 | 1991 | 18 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2013 | 4329 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 81 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 1992 | 16 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 1993 | 48 | 0.030 |
Why?
|
| Chicago | 2 | 2013 | 1434 | 0.030 |
Why?
|
| Homozygote | 1 | 1992 | 200 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1929 | 0.030 |
Why?
|
| Hyperprolactinemia | 1 | 1991 | 5 | 0.020 |
Why?
|
| Insemination, Artificial | 1 | 1991 | 16 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 5558 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 195 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1714 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 64 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 1991 | 69 | 0.020 |
Why?
|
| Sensation | 1 | 1991 | 47 | 0.020 |
Why?
|
| Ovulation Detection | 1 | 1990 | 6 | 0.020 |
Why?
|
| Middle Aged | 3 | 2013 | 26146 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1992 | 682 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1990 | 38 | 0.020 |
Why?
|
| Oocyte Retrieval | 1 | 2010 | 5 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 1990 | 14 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1999 | 1180 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 199 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1993 | 549 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1989 | 119 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1989 | 63 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2009 | 50 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 6409 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 776 | 0.020 |
Why?
|
| Biomarkers | 2 | 2005 | 1778 | 0.020 |
Why?
|
| Mutation | 1 | 1996 | 4168 | 0.010 |
Why?
|
| Triplets | 1 | 2003 | 8 | 0.010 |
Why?
|
| Pregnancy, Multiple | 1 | 2003 | 37 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 72 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1992 | 2360 | 0.010 |
Why?
|
| Twins | 1 | 2003 | 65 | 0.010 |
Why?
|
| Blastocyst | 1 | 2003 | 35 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 778 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1999 | 837 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 2456 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1913 | 0.010 |
Why?
|
| Insulin | 2 | 1999 | 1148 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 1732 | 0.010 |
Why?
|
| Sperm Motility | 1 | 1999 | 11 | 0.010 |
Why?
|
| Sperm Count | 1 | 1999 | 9 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 1999 | 41 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 1999 | 37 | 0.010 |
Why?
|
| Testis | 1 | 1999 | 152 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1999 | 511 | 0.010 |
Why?
|
| Abatacept | 1 | 1998 | 86 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 227 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 503 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 1998 | 140 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 591 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2767 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1998 | 466 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1999 | 899 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19254 | 0.010 |
Why?
|
| Biopsy | 1 | 1999 | 1184 | 0.010 |
Why?
|
| Prevalence | 1 | 1999 | 1250 | 0.010 |
Why?
|
| Pedigree | 1 | 1996 | 969 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1997 | 872 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1993 | 39 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 182 | 0.010 |
Why?
|
| C-Peptide | 1 | 1993 | 179 | 0.010 |
Why?
|
| Oligomenorrhea | 1 | 1992 | 11 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1992 | 25 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 2497 | 0.010 |
Why?
|
| Acne Vulgaris | 1 | 1992 | 35 | 0.010 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 1991 | 2 | 0.010 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 1991 | 4 | 0.010 |
Why?
|
| Menotropins | 1 | 1991 | 21 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 3678 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 1991 | 42 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1990 | 63 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1990 | 21 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1990 | 223 | 0.010 |
Why?
|
| Catheterization | 1 | 1991 | 237 | 0.010 |
Why?
|
| Vagina | 1 | 1991 | 177 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 3771 | 0.010 |
Why?
|
| Aging | 1 | 1990 | 727 | 0.000 |
Why?
|
| Animals | 1 | 1993 | 27528 | 0.000 |
Why?
|